- Home
- ARWR vs RVTY Comparison
ARWR vs RVTY Comparison
Compare ARWR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | RVTY |
|---|---|---|
| Founded | 2003 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 11.8B |
| IPO Year | 2009 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ARWR | RVTY |
|---|---|---|
| Price | $58.19 | $89.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | $81.50 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.31% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | 0.22 | ★ 2.07 |
| Revenue | $16,142,321.00 | ★ $3,311,822,000.00 |
| Revenue This Year | N/A | $6.34 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | $269.95 | ★ $43.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.66 | $81.36 |
| 52 Week High | $76.76 | $118.30 |
Technical Indicators
Market Signals| Indicator | ARWR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 36.19 | 33.51 |
| Support Level | $36.34 | $88.42 |
| Resistance Level | $66.37 | $94.75 |
| Average True Range (ATR) | 3.00 | 3.01 |
| MACD | -0.49 | -0.59 |
| Stochastic Oscillator | 13.32 | 7.08 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.